Tweet
Triangle Business Journal
<img alt="" height="1" width="1" />
Biogen, Elan plan Tysabri product label update
Bloomberg
By AP WESTON, Mass. (AP) — Biogen Idec and Elan Corp. said Wednesday they have applied to US and European regulators to update prescribing information for the multiple sclerosis drug Tysabri to help classify the risk of a rare but serious brain ...
PML Risk Test Urged With NatalizumabMedPage Today
Biogen wants to put PML risk test on Tysabri labelFiercePharma
Biogen Aims to Reduce PML RiskXconomy
TheStreet.com -Zacks.com -Forex Pros
all 45 news articles »
More...